PT85567A - Monoclonal antibodies and peptides useful in treating and diagnosing hiv infections - Google Patents

Monoclonal antibodies and peptides useful in treating and diagnosing hiv infections

Info

Publication number
PT85567A
PT85567A PT85567A PT8556787A PT85567A PT 85567 A PT85567 A PT 85567A PT 85567 A PT85567 A PT 85567A PT 8556787 A PT8556787 A PT 8556787A PT 85567 A PT85567 A PT 85567A
Authority
PT
Portugal
Prior art keywords
treating
monoclonal antibodies
hiv infections
peptides useful
diagnosing hiv
Prior art date
Application number
PT85567A
Other languages
English (en)
Other versions
PT85567B (pt
Inventor
Mary Kathleen Shriver
Larry H Gosting
Edna S Dickinson
Janela Nmi Mcclure
Robert C Nowinski
Elaine K Thomas
Wesley L Cosand
George J Todaro
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of PT85567A publication Critical patent/PT85567A/pt
Publication of PT85567B publication Critical patent/PT85567B/pt

Links

Classifications

    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
    • F04B25/00—Multi-stage pumps
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K16/1143—
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • AIDS & HIV (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Mechanical Engineering (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT85567A 1986-08-20 1987-08-20 Anticorpos monoclonais e peptidos apropriados para o tratamento e o diagnostico de infeccoes provocadas por hiv PT85567B (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89827386A 1986-08-20 1986-08-20
US4502687A 1987-05-01 1987-05-01
US6799687A 1987-06-29 1987-06-29

Publications (2)

Publication Number Publication Date
PT85567A true PT85567A (en) 1987-09-01
PT85567B PT85567B (pt) 1991-02-08

Family

ID=27366600

Family Applications (1)

Application Number Title Priority Date Filing Date
PT85567A PT85567B (pt) 1986-08-20 1987-08-20 Anticorpos monoclonais e peptidos apropriados para o tratamento e o diagnostico de infeccoes provocadas por hiv

Country Status (28)

Country Link
JP (1) JPS6485928A (pt)
KR (1) KR920008744B1 (pt)
AT (1) AT398080B (pt)
AU (1) AU616156B2 (pt)
BE (1) BE1000811A4 (pt)
CH (1) CH675728A5 (pt)
CS (1) CS275838B6 (pt)
DE (1) DE3727703A1 (pt)
DK (1) DK433087A (pt)
ES (1) ES2010727A6 (pt)
FI (1) FI873553A7 (pt)
FR (1) FR2603107B1 (pt)
GB (1) GB2196634B (pt)
GR (1) GR871298B (pt)
HU (1) HU214439B (pt)
IE (1) IE60671B1 (pt)
IL (1) IL83580A (pt)
IT (1) IT1222518B (pt)
LU (1) LU86972A1 (pt)
NL (1) NL8701950A (pt)
NO (2) NO300462B1 (pt)
NZ (1) NZ221440A (pt)
OA (1) OA08652A (pt)
PL (1) PL155084B1 (pt)
PT (1) PT85567B (pt)
SE (1) SE506025C2 (pt)
YU (1) YU152587A (pt)
ZW (1) ZW15487A1 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP96A (en) * 1986-06-03 1990-08-12 The Usa Dept Of Commerce Small peptides which inhibit binding to T-4 receptors and act as immunogens.
AU625720B2 (en) * 1987-05-01 1992-07-16 Genetic Systems Corporation Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
US6657050B1 (en) 1987-05-29 2003-12-02 Tanox, Inc. Chimeric viral-neutralizing immunoglobulins
WO1988009181A2 (en) * 1987-05-29 1988-12-01 Tanox Biosystems, Inc. Monoclonal antibodies neutralizing hiv-1
US5981278A (en) * 1987-05-29 1999-11-09 Tanox, Inc. Chimeric monoclonal antibodies which neutralize HIV-1 infection and their applications in therapy and prevention for AIDS
US5834599A (en) * 1987-05-29 1998-11-10 Tanox Biosystems, Inc. Immunoconjugates which neutralize HIV-1 infection
ATE138077T1 (de) * 1988-01-26 1996-06-15 Us Health Synthetisches antigen zum bewirken einer anti-hiv-reaktion
CA1341285C (en) * 1988-02-12 2001-08-14 Chang Yi Wang Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines
IL90048A0 (en) * 1988-04-25 1989-12-15 Merck & Co Inc Recombinant gag precursor of hiv,its preparation and its use as aids vaccine
US5562905A (en) * 1988-04-26 1996-10-08 E. I. Du Pont De Nemours And Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
EP0339504A3 (en) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
FR2632310B1 (fr) * 1988-06-06 1992-04-10 Pasteur Institut Peptides ayant des proprietes protectrices d'un virus pathogene du type hiv dans des cellules sensibles
JPH04502760A (ja) * 1988-10-03 1992-05-21 レプリゲン・コーポレーション エイズの診断，予防および治療に有効な新規ｈｉｖ蛋白質およびペプチド
CA2025481A1 (en) * 1989-09-19 1991-03-20 Peter J. Kniskern Vaccine for aids and hepatitis b
SE9000333D0 (sv) * 1990-01-31 1990-01-31 Britta Wahren Monoklonal antikropp
SE468168B (sv) * 1990-02-20 1992-11-16 Replico Medical Ab Hiv-1, p24 peptider, diagnostiska antigener och foerfarande foer saerskiljande diagnostik av preliminaert hiv-1 positiva serumprov
JPH03271233A (ja) * 1990-03-19 1991-12-03 Inst Pasteur ウイルスエンベロープ糖タンパク質及びその糖タンパク質の中和エピトープに対応するペプチドの間の相乗作用による、ウイルス性感染に対する防御の誘発
CA2047078A1 (en) * 1990-07-19 1992-01-20 Steven S. Bondy Cyclic hiv principal neutralizing determinant peptides
CA2047042A1 (en) * 1990-07-19 1992-01-20 John Hannah Cyclic hiv principal neutralizing determinant peptides
JPH05310785A (ja) * 1991-09-30 1993-11-22 Nitto Denko Corp Ｈｉｖ関連環状ペプチドおよびこれを固定化した吸着体
EP0960886B1 (en) * 1992-03-27 2004-05-26 Advanced Immuni T, Inc. Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis
EP2783697B1 (en) 2005-12-09 2017-01-11 Vectus Biosystems Limited VIP Fragments and uses thereof
EP2323233B1 (en) 2008-09-02 2017-10-11 NGK Spark Plug Co., Ltd. Spark plug
KR102727239B1 (ko) * 2022-09-07 2024-11-07 한국세라믹기술원 산화 마그네슘　분말 및 그의 제조방법

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9328391B1 (en) * 1984-08-22 2016-05-03 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Cloning and expression of HIV-1 DNA
EP1279678B1 (en) * 1984-10-18 2007-09-12 Institut Pasteur Gag antigen and its use for the detection of lav infection and in immunogenic compositions
GB8501473D0 (en) * 1985-01-21 1985-02-20 Pasteur Institut Cloned dna sequences
CA1341423C (en) * 1984-10-31 2003-03-04 Paul A. Luciw Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
IE64785B1 (en) * 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
EP0220234B1 (en) * 1985-04-08 1994-08-03 Genetic Systems Corporation EXPRESSION AND DIAGNOSTIC USE OF gag ENCODED PEPTIDES WHICH ARE IMMUNOLOGICALLY REACTIVE WITH ANTIBODIES TO LAV
DK171119B1 (da) * 1985-04-19 1996-06-17 Hoffmann La Roche AIDS-viruskappeprotein, ekspressionsvektor bærende viruskappeproteinet, transformanter transformeret med ekspressionsvektoren, fremgangsmåde til fremstilling af viruskappeproteinet, fremgangsmåde til detektion af AIDS-antistoffer, fremgangsmåde til bestemmelse af AIDS-virus, vaccine mod AIDS, antistoffer mod viruskappeproteinet samt anvendelse af dette til fremstilling af en vaccine og til testnin
ATE116006T1 (de) * 1985-04-29 1995-01-15 Genetic Systems Corp Synthetische antigene zum nachweis von aids.
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
EP0245362B1 (en) * 1985-10-24 1994-06-29 Ronald C. Kennedy Synthetic peptides and use for diagnosis and vaccination for aids and arc
WO1987002988A1 (en) * 1985-11-07 1987-05-21 President And Fellows Of Harvard College T-cell lymphotrophic virus protein and assay
US4772547A (en) * 1986-02-03 1988-09-20 Hoffmann-La Roche Inc. HTLV-III envelope peptides
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
IE63109B1 (en) * 1986-06-23 1995-03-22 Genetic Systems Corp Human monoclonal antibody to lymphadenopathy-associated virus
EP0525828A3 (en) * 1986-08-01 1993-02-24 Repligen Corporation Recombinant polypeptides and their uses, including assay for aids virus
JPH0762031B2 (ja) * 1986-12-30 1995-07-05 アメリカ合衆国 エイズウイルスおよびエイズウイルスのタンパク質に対する細胞性免疫を誘導する合成ペプチド

Also Published As

Publication number Publication date
LU86972A1 (fr) 1988-03-02
DK433087D0 (da) 1987-08-19
NO302176B1 (no) 1998-02-02
IL83580A0 (en) 1988-01-31
IT1222518B (it) 1990-09-05
SE8703225L (sv) 1988-02-21
NZ221440A (en) 1991-11-26
CS275838B6 (en) 1992-03-18
GR871298B (en) 1988-01-12
NO873495L (no) 1988-02-22
AT398080B (de) 1994-09-26
ATA208987A (de) 1994-01-15
KR920008744B1 (ko) 1992-10-09
ZW15487A1 (en) 1988-09-14
PT85567B (pt) 1991-02-08
HU214439B (hu) 1998-03-30
FI873553A0 (fi) 1987-08-17
IE60671B1 (en) 1994-08-10
NL8701950A (nl) 1988-03-16
DE3727703A1 (de) 1988-05-05
FI873553L (fi) 1988-02-21
KR890002547A (ko) 1989-04-10
SE506025C2 (sv) 1997-11-03
BE1000811A4 (fr) 1989-04-11
FR2603107B1 (fr) 1992-04-24
PL155084B1 (en) 1991-10-31
SE8703225D0 (sv) 1987-08-19
YU152587A (sh) 1992-09-07
GB2196634A (en) 1988-05-05
CH675728A5 (pt) 1990-10-31
NO873495D0 (no) 1987-08-19
GB2196634B (en) 1991-05-15
DK433087A (da) 1988-02-21
NO300462B1 (no) 1997-06-02
JPS6485928A (en) 1989-03-30
OA08652A (fr) 1988-11-30
GB8719587D0 (en) 1987-09-23
IE872219L (en) 1988-02-20
IL83580A (en) 1992-11-15
FR2603107A1 (fr) 1988-02-26
ES2010727A6 (es) 1989-12-01
FI873553A7 (fi) 1988-02-21
PL267401A1 (en) 1988-07-21
HUT44619A (en) 1988-03-28
CS8706136A2 (en) 1990-08-14
NO934897L (no) 1993-12-29
AU7720187A (en) 1988-05-19
AU616156B2 (en) 1991-10-24
NO934897D0 (no) 1993-12-29
IT8721678A0 (it) 1987-08-19

Similar Documents

Publication Publication Date Title
PT85567A (en) Monoclonal antibodies and peptides useful in treating and diagnosing hiv infections
GB2102810B (en) Human interferon-related peptides antigens antibodies and process for preparing the same
GB9009549D0 (en) Recombinant antibody and method
IL87535A0 (en) Cell lines and monoclonal antibodies
IL88160A0 (en) Cell lines and monoclonal antibodies
EP0240344A3 (en) Monoclonal antibodies and their use
NZ234049A (en) Peptide epitopes of, and antibodies to htlv-1
IL87730A0 (en) Peptides and antibodies
GB8621910D0 (en) Monoclonal antibodies
EP0267601A3 (en) Anti-pci monoclonal antibody
JPS6471482A (en) Cell line and antiepiglycanin monoclonal antibody produced thereby
GB8616174D0 (en) Monoclonal antibodies
IL96369A0 (en) Decapeptide,monoclonal antibodies directed thereto and their use in diagnosis
EP0363712A3 (en) Hybrid monoclonal antibodies, their production and use
ZM6687A1 (en) Monoclonal antibodies and peptides useful in treating and diagnosing hiv infections
GB8921227D0 (en) Antibodies and proteins
IL86678A0 (en) Hybrid cell line and monoclonal antibodies
GB8830115D0 (en) Monoclonal antibody and preparation and use thereof
PL273796A1 (en) Monoclonal antibody and method for diagnosing phytophthora infections
GB8610203D0 (en) Monoclonal antibodies
GB8610202D0 (en) Monoclonal antibodies
EP0252768A3 (en) Anti-lafora body monoclonal antibody
IL132469A (en) Antibody composition comprising anti - hcv - antibodies and immunoassay using such antibodies
GB8820923D0 (en) Peptide sequence & antibody thereto
IE892973L (en) Antigen and immunodiagnostic method

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19991231